Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 health care workers in Catalonia who were followed for three years. The study, led by ISGlobal ...
Apr 8, 2025
0
4
Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the introduction of vaccines in the 1940s. In the decades since, the bacterial disease was nearly eradicated in ...
Apr 5, 2025
0
55
A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The system ...
Apr 7, 2025
0
22
A vaccine to fight dementia? It turns out there may already be one—shots that prevent painful shingles also appear to protect aging brains.
Apr 6, 2025
0
11
A new study published in JAMA Psychiatry sheds light on how cannabis use disorder is linked to changes in the brain that are associated with psychosis.
Apr 9, 2025
0
76
Individuals who were conceived in colder seasons are more likely to show higher brown adipose tissue activity, increased energy expenditure and a lower body mass index (BMI), and lower fat accumulation around internal organs, ...
Apr 7, 2025
0
92
Osteoarthritis is the leading cause of disability and chronic pain worldwide, affecting an estimated 595 million people globally. Projections suggest that this number will rise to 1 billion by 2050. Despite its profound impact ...
Apr 9, 2025
0
23
Heavy drinkers who have eight or more alcoholic drinks per week have an increased risk of brain lesions called hyaline arteriolosclerosis, signs of brain injury that are associated with memory and thinking problems, according ...
Apr 9, 2025
0
52
As many as one in 3,000 people could be carrying a faulty gene that significantly increases their risk of a punctured lung, according to new estimates from Cambridge researchers. Previous estimates had put this risk closer ...
Apr 7, 2025
0
63
Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS)—improves neuron health in animal models ...
Apr 8, 2025
0
28
